Showing results (2481-2490 of 3,836) with videos related to
Sort By:
Pageof 384
Cancer Cell|June 14, 2011
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.Cancer Cell|June 14, 2011
Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growthAnnarita Miluzio, Anne Beugnet, Stefano Grosso, et al.Cancer Cell|November 8, 2016
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic LeukemiaLili Wang, Angela N Brooks, Jean Fan, et al.Cancer Cell|December 20, 2016
Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem CellsZhongwei Cao, Joseph M Scandura, Giorgio G Inghirami, et al.Cancer Cell|January 11, 2017
Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKTJuliane Paul, Maurice Soujon, Antje M Wengner, et al.Cancer Cell|January 11, 2017
BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal CancerCarlos López-García, Laurent Sansregret, Enric Domingo, et al.Cancer Cell|May 6, 2014
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expressionChunxiao Xu, Christine M Fillmore, Shohei Koyama, et al.Cancer Cell|April 22, 2014
Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progressionTaoyong Chen, Mingjin Yang, Zhou Yu, et al.Cancer Cell|April 22, 2014
Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumorsPiro Lito, Anna Saborowski, Jingyin Yue, et al.Pageof 384